Old Web
Pilot study of intra-arterial bevacizumab for hepatocellular carcinoma HCC
2008
15681 Background: HCC is a major cause of cancer death worldwide with limited and minimally efficacious therapeutic options foro advanced HCC. Bevacizumab is a monoclonal antibody against VEGFA pil...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI